Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Endocrine journal

• Publication date

  2013-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1507/ENDOCRJ.EJ12-0343PMID 23154532
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate

  2012cited by this paper
• The functional and molecular characterisation of human embryonic stem cell-derived insulin-positive cells compared with adult pancreatic beta cells

  2012cited by this paper
• Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study.

  2012cited by this paper
• Comparison of human amniotic fluid-derived and umbilical cord Wharton's Jelly-derived mesenchymal stromal cells: Characterization and myocardial differentiation capacity

  2012cited by this paper
• THE LAST TEN YEARS

  2012cited by this paper
• Immunosuppressive properties of mesenchymal stem cells: advances and applications.

  2012cited by this paper
• Transplanted Human Bone Marrow Progenitor Subtypes Stimulate Endogenous Islet Regeneration and Revascularization

  2012cited by this paper
• Mesenchymal stem cell-based therapy for the treatment of type 1 diabetes mellitus.

  2012cited by this paper
• Glucose-stimulated insulin secretion of various mesenchymal stem cells after insulin-producing cell differentiation.

  2012cited by this paper
• Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats

  2012cited by this paper
• Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells.

  2012cited by this paper
• Co-transplantation of mesenchymal stem cells maintains islet organisation and morphology in mice

  2011cited by this paper
• HLA Genes, Islet Autoantibodies and Residual C-Peptide at the Clinical Onset of Type 1 Diabetes Mellitus and the Risk of Retinopathy 15 Years Later

  2011cited by this paper
• Wharton’s Jelly Mesenchymal Stem Cells as Candidates for Beta Cells Regeneration: Extending the Differentiative and Immunomodulatory Benefits of Adult Mesenchymal Stem Cells for the Treatment of Type 1 Diabetes

  2011cited by this paper
• Transplantation of Insulin-Producing Cells Derived from Umbilical Cord Stromal Mesenchymal Stem Cells to Treat NOD Mice

  2011cited by this paper
• Impact of enhanced mobilization of bone marrow derived cells to site of injury.

  2011cited by this paper
• New Insights into Mesenchymal Stromal Cell‐Mediated T‐Cell Suppression Through Galectins

  2011cited by this paper
• Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I

  2011cited by this paper
• Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus.

  2011cited by this paper
• Intravenous Infusion of Mesenchymal Stem Cells Is Associated With Improved Myocardial Function During Endotoxemia

  2011cited by this paper
• Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study.

  2011cited by this paper
• Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair

  2010cited by this paper
• Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.

  2010cited by this paper
• Mesenchymal stem cells protect islets from hypoxia/reoxygenation‐induced injury

  2010cited by this paper
• Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes.

  2010cited by this paper
• Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

  2010cited by this paper
• Genetics, pathogenesis and clinical interventions in type 1 diabetes

  2010cited by this paper
• Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study

  2010cited by this paper
• Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report.

  2010cited by this paper
• Mesenchymal Stem Cells: Mechanisms of Immunomodulation and Homing

  2010cited by this paper
• Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.

  2009cited by this paper
• Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes1

  2009cited by this paper
• In vivo differentiation of human umbilical cord blood-derived cells into insulin-producing beta cells.

  2009cited by this paper
• C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.

  2009cited by this paper
• Dynamic analysis of bone marrow mesenchymal stem cells migrating to pancreatic islets using coculture microfluidic chips: An accelerated migrating rate and better survival of pancreatic islets were revealed.

  2009cited by this paper
• Reducing postprandial hyperglycemia with adjuvant premeal pramlintide and postmeal insulin in children with type 1 diabetes mellitus

  2009cited by this paper
• Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells

  2009cited by this paper
• Biodistribution, Long-term Survival, and Safety of Human Adipose Tissue-derived Mesenchymal Stem Cells Transplanted in Nude Mice by High Sensitivity Non-invasive Bioluminescence Imaging

  2008cited by this paper
• Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice

  2006cited by this paper
• Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets.

  2005cited by this paper
• diabetes mellitus and

  2001cited by this paper
• Immunoregulatory and Cytokine Imbalances in the Pathogenesis of IDDM: Therapeutic Intervention by Immunostimulation?

  1994cited by this paper

• Efficacy and safety of stem cell therapy in patients with Diabetes Mellitus - a systematic review and meta-analysis.

  2026cites this paper
• Overview of the Major Clinical Trials Investigating Stem Cells-based Therapies for Diabetes.

  2026cites this paper
• Immune Evasion in Stem Cell-Based Diabetes Therapy—Current Strategies and Their Application in Clinical Trials

  2025cites this paper
• Wharton's jelly mesenchymal stem cells (WJ-MSCs), a "Holy Grail" in tissue bioengineering and reconstructive medicine.

  2025cites this paper
• Mesenchymal stem cell therapy for diabetes: An umbrella review.

  2025cites this paper
• Safety and efficacy of umbilical cord mesenchymal stem cells in the treatment of type 1 and type 2 diabetes mellitus: a systematic review and meta-analysis

  2025influential citation
• Integrated strategies from stem cells to exosomes for amelioration of insulin resistance and promoting β-cell regeneration in diabesity.

  2025cites this paper
• Preventing the onset of diabetes with precision delivery of mesenchymal stem cells to the pancreas in a preclinical model

  2025cites this paper
• Maturity-Onset Diabetes of the Young 10 (MODY10): A Comprehensive Review of Genetics, Clinical Features, and Therapeutic Advances

  2025cites this paper
• Novel methodologies for the treatment of type 1 diabetes mellitus using in silico tools

  2025cites this paper
• A systematic review and network meta-analysis of interventions to preserve insulin-secreting beta cell function in people newly diagnosed with type 1 diabetes: results from randomised controlled trials of immunomodulatory therapies

  2025cites this paper
• Mesenchymal stem cell-based therapy for type 1 & 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials

  2025cites this paper
• Role of Perinatal Stem Cell Secretome as Potential Therapy for Muscular Dystrophies

  2025cites this paper
• Dentinogenic Effect of BMP-7 on Wharton’s Jelly Mesenchymal Stem Cells Cultured in Decellularized Dental Pulp

  2025cites this paper
• Tissue Engineering and Regenerative Medicine: Perspectives and Challenges

  2025cites this paper
• A meta-analysis on application and prospect of cell therapy in the treatment of diabetes mellitus

  2025cites this paper
• Body composition changes across a spectrum of hypothyroidism severity - a systematic review and meta-analysis

  2025cites this paper
• Hypoimmune stem cells and islets: hype or a true breakthrough in diabetes treatment?

  2025cites this paper
• Utilization of Stem Cells in Medicine: A Narrative Review

  2025cites this paper
• From Cord to Cure: Repurposing Biological Waste for UAE's Health Revolution with Umbilical Cord Stem Cell Therapy

  2024cites this paper
• Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities

  2024cites this paper
• Culturing Conditions Dictate the Composition and Pathways Enrichment of Human and Rat Perirenal Adipose-Derived Stromal Cells’ Secretomes

  2024cites this paper
• Bibliometric analysis of organoids in regenerative medicine-related research worldwide over two decades (2002-2022).

  2024cites this paper
• Human mesenchymal stem/stromal cell based-therapy in diabetes mellitus: experimental and clinical perspectives

  2024influential citation
• Strategy for Clinical Setting of Co-transplantation of Mesenchymal Stem Cells and Pancreatic Islets

  2024cites this paper
• Meta-analysis shows that mesenchymal stem cell therapy can be a possible treatment for diabetes

  2024cites this paper
• Potentials of bone marrow cells-derived from naïve or diabetic mice in autoimmune type 1 diabetes: immunomodulatory, anti-inflammatory, anti hyperglycemic, and antioxidative

  2024cites this paper
• Innovative Immunotherapies and Emerging Treatments in Type 1 Diabetes Management

  2024cites this paper
• Role of genetically engineered mesenchymal stem cell exosomes and LncRNAs in respiratory diseases treatment.

  2024cites this paper
• Efficacy of mesenchymal stromal cells in the treatment of type 1 diabetes: a systematic review

  2024influential citation
• Cell Therapies and Gene Therapy for Diabetes: Current Progress.

  2024cites this paper
• Current status of stem cell therapy for type 1 diabetes: a critique and a prospective consideration

  2024cites this paper
• HucMSCs can alleviate abnormal vasculogenesis induced by high glucose through the MAPK signaling pathway

  2024cites this paper
• Stem Cells Therapy for Diabetes Mellitus Type 1. An Update on Safety and Outcomes

  2023influential citation
• Human umbilical cord-derived mesenchymal stem cells alleviate oxidative stress-induced islet impairment via the Nrf2/HO-1 axis

  2023cites this paper
• Human Hematopoietic Stem/Progenitor Cells in Type One Diabetes Mellitus Treatment: Is There an Ideal Candidate?

  2023cites this paper
• Stem Cell Therapy for the Management of Type 1 Diabetes: Advances and Perspectives.

  2023cites this paper
• Decoding Sepsis-Induced Disseminated Intravascular Coagulation: A Comprehensive Review of Existing and Emerging Therapies

  2023cites this paper
• Umbilical cord mesenchymal stromal cells transplantation delays the onset of hyperglycemia in the RIP-B7.1 mouse model of experimental autoimmune diabetes through multiple immunosuppressive and anti-inflammatory responses

  2023cites this paper
• Clinical Application of Umbilical Cord Mesenchymal Stem Cells Preserves β-cells in Type 1 Diabetes

  2023cites this paper
• Stem cells therapy for diabetes: from past to future.

  2023cites this paper
• Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I/II randomised double-blind placebo-controlled trial

  2023cites this paper
• Wharton’s jelly mesenchymal stem cells: a concise review of their secretome and prospective clinical applications

  2023cites this paper
• A Supportive Role of Mesenchymal Stem Cells on Insulin-Producing Langerhans Islets with a Specific Emphasis on The Secretome

  2023cites this paper
• Immunomodulatory Mechanism and Potential Application of Dental Pulp-Derived Stem Cells in Immune-Mediated Diseases

  2023cites this paper
• Adipose Tissue-Derived Stromal/Stem Cells Transplantation with Cholecalciferol Supplementation in Recent-Onset Type 1 Diabetes Patients: Twelve Months Follow-Up

  2023cites this paper
• Addressing the impact of high glucose microenvironment on the immunosuppressive characteristics of human mesenchymal stem cells

  2023cites this paper
• Human umbilical cord-derived mesenchymal stem cells not only ameliorate blood glucose but also protect vascular endothelium from diabetic damage through a paracrine mechanism mediated by MAPK/ERK signaling

  2022cites this paper
• The Role of Mesenchymal Stem Cells in the Treatment of Type 1 Diabetes

  2022cites this paper
• The Inability of Ex Vivo Expanded Mesenchymal Stem/Stromal Cells to Survive in Newborn Mice and to Induce Transplantation Tolerance

  2022cites this paper
• Shining the light on clinical application of mesenchymal stem cell therapy in autoimmune diseases

  2022cites this paper
• Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis

  2022cites this paper
• Stem cell-based therapy for human diseases

  2022cites this paper
• Investigating the safety and efficacy of hematopoietic and mesenchymal stem cell transplantation for treatment of T1DM: a systematic review and meta-analysis

  2022cites this paper
• New therapeutic approaches for type 1 diabetes: Disease-modifying therapies

  2022cites this paper
• Prevention of chronic diabetic complications in type 1 diabetes by co-transplantation of umbilical cord mesenchymal stromal cells and autologous bone marrow: a pilot randomized controlled open-label clinical study with 8-year follow-up.

  2022cites this paper
• Perinatal Stem Cell Therapy to Treat Type 1 Diabetes Mellitus: A Never-Say-Die Story of Differentiation and Immunomodulation

  2022cites this paper
• Stem cell therapy for type 1 diabetes: a scientometric assessment of global research during the twenty-first century

  2022cites this paper
• hUCMSCs carrying exenatide prevent T1DM by improving intestinal microflora composition and islet tissue damage repair

  2022cites this paper
• Adipose tissue-derived stromal/stem cells transplantation + cholecalciferol in recent-onset type 1 diabetes patients: twelve months follow up

  2022cites this paper
• A Comparison of Mesenchymal Stem Cell Lineages for Treatment of Diabetes Mellitus

  2022cites this paper
• When stem cells meet COVID-19: recent advances, challenges and future perspectives

  2022cites this paper
• Clinical efficacy of stem-cell therapy on diabetes mellitus: A systematic review and meta-analysis.

  2022cites this paper
• Differentiation of Alginate-Encapsulated Wharton Jelly-Derived Mesenchymal Stem Cells into Insulin Producing Cells

  2022cites this paper
• Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes

  2022cites this paper
• Efficacy of mesenchymal stem cell transplantation therapy for type 1 and type 2 diabetes mellitus: a meta-analysis

  2021cites this paper
• Human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus: the emerging therapeutic approach

  2021cites this paper
• The Multi-Therapeutic Role of MSCs in Diabetic Nephropathy

  2021cites this paper
• Cell therapy in patients with heart failure: a comprehensive review and emerging concepts

  2021cites this paper
• Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases

  2021cites this paper
• Efficacy of Stem Cell Application in Diabetes Mellitus: Promising Future Therapy for Diabetes and Its Complications

  2021influential citation
• Injectable Mesenchymal Stem Cell‐Laden Matrigel Microspheres for Endometrium Repair and Regeneration

  2021cites this paper
• Diabetes type 1: Can it be treated as an autoimmune disorder?

  2021cites this paper
• Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era

  2021cites this paper
• Heterogeneity of mesenchymal stem cells in cartilage regeneration: from characterization to application

  2021cites this paper
• Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial

  2021influential citation
• Differentiation of Stem Cells into Hepatocyte Lineage: In Vitro Cell Culture, In Vivo Transplantation in Animal Models

  2021cites this paper
• The therapeutic applications of mesenchymal stromal cells from human perinatal tissues in autoimmune diseases

  2021influential citation
• Where Do We Stand in Stem Cell Therapy for the Management of Diabetes Mellitus?—A Scientometric Research Trend Analysis from 1990 to 2020

  2021cites this paper
• Human umbilical cord-derived mesenchymal stem/stromal cells: a promising candidate for the development of advanced therapy medicinal products

  2021cites this paper
• Therapeutic Implications of Mesenchymal Stromal Cells and Their Extracellular Vesicles in Autoimmune Diseases: From Biology to Clinical Applications

  2021cites this paper
• Delivery of therapeutic agents and cells to pancreatic islets: Towards a new era in the treatment of diabetes.

  2021cites this paper
• Stem Cell Therapy and Regenerative Medicine in Autoimmune Diseases

  2021cites this paper
• The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice

  2021cites this paper
• Therapeutic Aspects of Mesenchymal Stem Cell-Based Cell Therapy with a Focus on Human Amniotic Epithelial Cells in Multiple Sclerosis: A Mechanistic Review

  2021cites this paper
• Clinical efficacy on glycemic control and safety of mesenchymal stem cells in patients with diabetes mellitus: Systematic review and meta-analysis of RCT data

  2021influential citation
• Safety and immunological proof-of-concept following treatment with tolerance-inducing cell products in patients with autoimmune diseases or receiving organ transplantation: A systematic review and meta-analysis of clinical trials.

  2021cites this paper
• Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus

  2021cites this paper
• Effects of Four Antibiotics on the Diversity of the Intestinal Microbiota

  2021cites this paper
• One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes: an open parallel controlled clinical study

  2020cites this paper
• Identifying the Therapeutic Significance of Mesenchymal Stem Cells

  2020cites this paper
• Human Wharton’s Jelly—Cellular Specificity, Stemness Potency, Animal Models, and Current Application in Human Clinical Trials

  2020cites this paper
• Efficacy and safety of stem cells transplantation in patients with type 1 diabetes mellitus-a systematic review and meta-analysis.

  2020influential citation
• Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.

  2020cites this paper
• Umbilical Cord Blood and Cord Tissue Bank as a Source for Allogeneic Use

  2020cites this paper
• Preconditioning is an effective strategy for improving the efficiency of mesenchymal stem cells in kidney transplantation

  2020cites this paper
• Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.

  2020cites this paper
• Current Status and Future Prospects of Perinatal Stem Cells

  2020cites this paper
• The Clinical Efficacy and Safety of Stem Cell Therapy for Diabetes Mellitus: A Systematic Review and Meta-Analysis

  2020cites this paper
• miR‐196b‐5p inhibits proliferation of Wharton's jelly umbilical cord stem cells

  2020cites this paper